Abstract:Background: Gastric cancer (GC), a multifaceted gastrointestinal malignancy, is the fourth most prevalent contributor to cancer-related fatalities globally. As a member of the ATP-binding cassette (ABC) family, transporter associated with antigen processing 1 (TAP1) is crucial for conveying antigen peptides from the cytoplasm to the lumen of the endoplasmic reticulum and subsequently loading them onto the major histocompatibility complex (MHC) class I molecules. Recent studies have established the biological significance of TAP1 in upholding tumor survival and facilitating immune evasion by remodeling the tumor microenvironment (TME) and orchestrating immune infiltration. The study was conducted to elucidate the association of TAP1 expression with immunological characteristics, and sought to exploit the value of TAP1 as a biomarker reflecting the inflamed TME and immunotherapeutic response. Methods: RNA-sequencing profiles and clinical annotations were obtained from The Cancer Genome Atlas-stomach adenocarcinoma (TCGA-STAD) cohort and Gene Expression Omnibus (GEO) portal. Preprocessing was conducting using the limma package. Weighted gene co-expression network analysis (WGCNA) was used to identify gene modules and TAP1 co-expressed genes (CEGs) based on correlation patterns. Consensus clustering and silhouette analysis determined the optimal number of TAP1-related groups. Gene expression profiles were integrated and classified using the pamr package. The Estimation of STromal and Immune cells in MAlignant Tumors using Expression data (ESTIMATE) algorithm and single-sample gene set enrichment analysis (ssGSEA) were used to evaluate immunological characteristics. Differential expression analysis was conducted using the limma package. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed. Single-cell RNA sequencing (scRNA-seq) datasets were analyzed using the Seurat toolkit to characterize cell types. Results: Within this investigation, no significant differences in TAP1 expression were observed among patients exhibiting various clinicopathological features, indicating that TAP1 expression was not specific to molecular subtypes. Subsequent analysis revealed a positive correlation between TAP1 and diverse immunological traits, encompassing immunomodulators, tumor-infiltrating immune cells, as well as immune checkpoints across multiple datasets. Besides, within a GC immunotherapy cohort, individuals displaying high TAP1 expression demonstrated an increased likelihood of achieving complete remission (CR) post-treatment, suggesting heightened sensitivity to immunotherapy. In the clinical cohort, TAP1 overexpression in GC patients was positively correlated with CD8. Conclusions: TAP1 appears linked to an inflamed TME and serves as a prospective biomarker for discerning immunological attributes and gauging immunotherapeutic responses in GC, particularly in identifying immune-reactive tumors.

Expression of A-Tocopherol-associated Protein (TAP) is Associated with Clinical Outcome in Breast Cancer Patients.

Reduced Expression of Tocopherol-Associated Protein (TAP/Sec14L2) in Human Breast Cancer

α-Tocopherol-associated Protein Suppresses Prostate Cancer Proliferation by Phosphoinositide 3-Kinase Pathway

High Trophinin‑Associated Protein Expression and Its Role in Prognosis of Pancreatic Cancer

Effect of Α-Tocopherol Associated Protein in the Regulation of the Apoptosis Induced by Oxidative Stress in Prostate Cancer Cells

Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis

Involvement of PD-L1-mediated Tumor-Intrinsic Signaling and Immune Suppression in Tumorigenic Effect of Α-Tocopherol.

Exploring the potential of tocopherols: mechanisms of action and perspectives in the prevention and treatment of breast cancer

Increased Expression of TAP is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer

Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers

FEAT Expression Correlates with Tumor Size, PR Status, HER2 Expression, Ki67 Index, and Molecular Subtype and Predicts Recurrence in Breast Cancer

TROAP Promotes Breast Cancer Proliferation and Metastasis

Transporter Associated with Antigen Processing 1 (TAP1) as a Potential Biomarker for Breast, Lung, Liver and Ovarian Cancer using Health Informatics

The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation

Pan-cancer analysis: Predictive role of TAP1 in cancer prognosis and responses of immunotherapy

Clinical Application of Serum Tumor Abnormal Protein (TAP) in Colorectal Cancer Patients

Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma

Effect of Α-Tocopheryl Succinate on IAPs Expression in Human Breast Cancer Cells

Upregulated WTAP expression appears to both promote breast cancer growth and inhibit lymph node metastasis

The relationship between TEAD gene family and prognosis, tumor microenvironment and therapeutic target by pan-cancer analysis